Gonzo journalism about cats?

This week one of my sources sent me a recent newsletter from linkurl:Allerca,;http://www.allerca.com/indexold.html a "lifestyle pets" company now headquartered in Delaware that claims to have developed hypoallergenic cats. I was interested to read a rant by the company's founder, Simon Brodie, about the "gonzo journalists" who "trumpeted absolute falsehoods and downright lies" regarding the company. I imagine Brodie might be referring to yours truly. Not because I lied in my linkurl:investigati

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
This week one of my sources sent me a recent newsletter from linkurl:Allerca,;http://www.allerca.com/indexold.html a "lifestyle pets" company now headquartered in Delaware that claims to have developed hypoallergenic cats. I was interested to read a rant by the company's founder, Simon Brodie, about the "gonzo journalists" who "trumpeted absolute falsehoods and downright lies" regarding the company. I imagine Brodie might be referring to yours truly. Not because I lied in my linkurl:investigation;http://www.the-scientist.com/article/display/39383/ of Allerca, but because what I found out about the company was not exactly favorable, and, as far as I can tell, __The Scientist__ and the __San Diego Union Tribune__ are among the few outlets that actually reported with skepticism the wonders of these miracle cats. I left a message with Allerca's press office, asking if __The Scientist__ was included in this gonzo bunch, but did not receive an immediate response. Brodie claims that these gonzo journalists "went very quiet (surprise, surprise!) once ALLERCA began delivering kittens. They didn't write about ALLERCA when our cats appeared on live national television with allergic individuals who failed to have any allergic reaction (talk about a "trial by fire"!); and they failed to report that ALLERCA had won a TIME Magazine Best Inventions of 2006 award." But the only customers I've heard from were those who were linkurl:denied cats;http://www.the-scientist.com/blog/display/53265/ because of their particular allergic profiles, and who complained that their refunds did not come back. Shortly after they contacted me, both customers received their refunds. And as far as silence goes, I had called Allerca months ago to ask them about the linkurl:progress of their cats,;http://www.the-scientist.com/blog/display/52947/ and received no word. Hunter S. Thompson's somewhat autobiographical adventures in gonzo journalism highlight the fact that no reporter can completely divorce himself from his own way of viewing the world. As a science writer, trained in science, I admit to being skeptical of claims that have no vetted data to support them. To me, bringing a cat on a TV show is not scientific proof that its Fel d1 protein has been disabled. A scientific publication is a start, and anything less I consider gonzo.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution